These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 10981547

  • 1. Amlodipine is comparable to angiotensin-converting enzyme inhibitor for long-term renoprotection in hypertensive patients with renal dysfunction: a one-year, prospective, randomized study.
    Kumagai H, Hayashi K, Kumamaru H, Saruta T.
    Am J Hypertens; 2000 Sep; 13(9):980-5. PubMed ID: 10981547
    [Abstract] [Full Text] [Related]

  • 2. Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease.
    Ecder T, Chapman AB, Brosnahan GM, Edelstein CL, Johnson AM, Schrier RW.
    Am J Kidney Dis; 2000 Mar; 35(3):427-32. PubMed ID: 10692268
    [Abstract] [Full Text] [Related]

  • 3. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [Abstract] [Full Text] [Related]

  • 4. Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial.
    Halimi JM, Giraudeau B, Buchler M, Al-Najjar A, Etienne I, Laouad I, Bruyère F, Lebranchu Y.
    Clin Transplant; 2007 Mar; 21(2):277-84. PubMed ID: 17425758
    [Abstract] [Full Text] [Related]

  • 5. Does combined therapy of Ca-channel blocker and angiotensin converting enzyme inhibitor exceed monotherapy in renal protection against hypertensive injury in rats?
    Kanno Y, Okada H, Suzuki H, Ikenaga H, Ishii N, Itoh H, Saruta T.
    Clin Exp Hypertens; 1996 Feb; 18(2):243-56. PubMed ID: 8869003
    [Abstract] [Full Text] [Related]

  • 6. Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
    Hayashi M, Uchida S, Kawamura T, Kuwahara M, Nangaku M, Iino Y, PROTECT-CKD Study Group.
    Clin Exp Nephrol; 2015 Oct; 19(5):925-32. PubMed ID: 25680887
    [Abstract] [Full Text] [Related]

  • 7. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
    Kanno Y, Okada H, Saruta T, Suzuki H.
    Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
    [Abstract] [Full Text] [Related]

  • 8. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T.
    Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647
    [Abstract] [Full Text] [Related]

  • 9. Blood pressure control and response rates with zofenopril compared with amlodipine in hypertensive patients.
    Farsang C.
    Blood Press Suppl; 2007 Oct 25; 2():19-24. PubMed ID: 18046975
    [Abstract] [Full Text] [Related]

  • 10. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
    Wright JT, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG, African American Study of Kidney Disease and Hypertension Study Group.
    JAMA; 2002 Nov 20; 288(19):2421-31. PubMed ID: 12435255
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of Hypertensive Patients With Diabetes and Microalbuminuria With Combination Indapamide SR/Amlodipine: Retrospective Analysis of NESTOR.
    Hanon O, Boully C, Caillard L, Labourée F, Cochiello S, Chaussade E.
    Am J Hypertens; 2015 Aug 20; 28(8):1064-71. PubMed ID: 25628416
    [Abstract] [Full Text] [Related]

  • 13. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients.
    Bunke M, Ganzel B.
    J Heart Lung Transplant; 1992 Aug 20; 11(6):1194-9. PubMed ID: 1457446
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
    Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT, Xu S, African American Study of Kidney Disease and Hypertension (AASK) Study Group.
    JAMA; 2001 Jun 06; 285(21):2719-28. PubMed ID: 11386927
    [Abstract] [Full Text] [Related]

  • 16. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep 06; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A prospective open-label randomised trial of quinapril and/or amlodipine in progressive non-diabetic renal failure.
    MacGregor MS, Deighan CJ, Rodger RS, Boulton-Jones JM.
    Nephron Clin Pract; 2005 Sep 06; 101(3):c139-49. PubMed ID: 16015004
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M, Martell Claros N, Study Investigators Group.
    Clin Ther; 2005 Feb 06; 27(2):166-73. PubMed ID: 15811479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.